Formlabs
Formlabs develops 3D printing systems, including its flagship Stereolithography (SLA) and Selective Laser Sintering (SLS) printers and materials.
Secondary Market Price
How Formlabs Measures Up
To help you manage your Formlabs equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series E
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Formlabs's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Formlabs Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Formlabs's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Formlabs designs and manufactures 3D printing systems, focusing on stereolithography (SLA) and selective laser sintering (SLS) technologies. The company provides hardware, such as its Form and Fuse series printers, alongside materials and software for various sectors including engineering, manufacturing, and healthcare. Real-world applications of its technology include Deutsche Bahn producing over 100,000 parts for train maintenance and the Superhumans Center in Ukraine using Formlabs printers for surgical planning and prosthetics. Founded in 2011 by Maxim Lobovsky and Natan Linder, the company is headquartered in Somerville, Massachusetts, with additional offices in Germany, Japan, China, Singapore, and Hungary. Formlabs has raised $256.1 million in total funding, with a Series E round in 2021 contributing to a $2 billion valuation that year.
The company continues to focus on expanding access to digital fabrication by developing new materials, software, and post-processing solutions. One recent development is the introduction of Cerakote ceramic coatings for SLA and SLS 3D printed parts, intended for use in the automotive, aerospace, and tooling industries. Formlabs has also updated its PreForm software with a new tool to support the SLS printing process. Other recent activities include a collaboration with the New England Patriots to test custom 3D-printed footballs and a Reddit AMA with its Chief Product Officer, David Lakatos. These efforts indicate a continued push into new applications and materials to support a broader range of industrial uses.
- SoftBank Vision Fund
- New Enterprise Associates
- DFJ Growth
- Pitango Venture Capital
- Shenzhen Capital Group
- Co-Founder, Maxim Lobovsky
- Co-Founder, David Cranor
- Co-Founder, Natan Linder
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Formlabs worth joining?
Evaluating an offer from a private company like Formlabs requires understanding the potential value of its equity compensation. Tools like Prospect can help you model the future value of your shares and make a more informed career decision.
What should I do with my Formlabs stock?
Deciding what to do with private stock involves complex tax and financial planning, including when to exercise options or sell shares. Platforms like Prospect provide personalized strategies to help you optimize your equity decisions and maximize its value.
Can you sell Formlabs stock?
As a private company, Formlabs stock is not publicly traded, but employees may have opportunities to sell shares through tender offers or secondary markets. Prospect's tender offer tools can help you decide how much to sell during these liquidity events.
How can I find the value of my Formlabs stock?
Valuing stock in a private company like Formlabs is challenging due to the lack of public market data. Prospect uses machine learning models and proprietary data to project the future value of your shares and help you understand what your equity could be worth.
What is Formlabs's equity worth?
The exact worth of private equity fluctuates, but you can estimate its potential value based on various factors. Using data-driven projections, predictive models like those offered by Prospect can help you forecast a range of likely outcomes for your Formlabs equity.
What is Formlabs's stock ticker symbol?
Formlabs is a private company, so it does not have a stock ticker symbol and is not traded on public stock exchanges. Ticker symbols are assigned to companies only when they become publicly listed through an Initial Public Offering (IPO).
Can I buy or sell Formlabs stock?
Selling stock in a private company like Formlabs is typically limited to specific liquidity events like tender offers, which Prospect can help you navigate. Buying stock is generally restricted to accredited investors or employees exercising their options.
What is the criteria to buy or invest in Formlabs stock?
Investing in a private company like Formlabs is typically restricted to institutional or accredited investors who meet specific financial thresholds. Employees can also acquire stock by exercising their stock options as part of their compensation package.
